Cargando…

A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia

CONTEXT: There are very few studies evaluating efficacy of platelet-rich plasma (PRP) in hair restoration and its combination with microneedling. As far as ascertained, there is no study to evaluate efficacy of microneedling with PRP plus topical minoxidil (5%) versus topical minoxidil (5%) alone in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Kaksha B, Shah, Aarti N, Solanki, Rekha B, Raval, Ranjan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514790/
https://www.ncbi.nlm.nih.gov/pubmed/28761259
http://dx.doi.org/10.4103/ijt.ijt_75_16
_version_ 1783250883043131392
author Shah, Kaksha B
Shah, Aarti N
Solanki, Rekha B
Raval, Ranjan C
author_facet Shah, Kaksha B
Shah, Aarti N
Solanki, Rekha B
Raval, Ranjan C
author_sort Shah, Kaksha B
collection PubMed
description CONTEXT: There are very few studies evaluating efficacy of platelet-rich plasma (PRP) in hair restoration and its combination with microneedling. As far as ascertained, there is no study to evaluate efficacy of microneedling with PRP plus topical minoxidil (5%) versus topical minoxidil (5%) alone in androgenetic alopecia (AGA). AIMS: This study aims (1) to compare the efficacy of (a) topical minoxidil (5%) alone and (b) topical minoxidil (5%) + microneedling with PRP in men between 18 and 50 years with AGA Grade III to V vertex (Norwood–Hamilton scale) and (2) to perform objective and subjective evaluation based on clinical improvement and photographic evidence. SETTINGS AND DESIGN: The study was conducted in the outpatient department of dermatology, venereology, and leprology in tertiary care hospital. It was open, prospective study. SUBJECTS AND METHODS: Fifty patients with AGA were selected on the basis of inclusion and exclusion criteria. These patients were randomly divided into two groups of 25 patients each and were given following treatment: (i) Group A: topical minoxidil (5%) alone and (ii) Group B: topical minoxidil (5%) + microneedling with platelet-rich plasma (PRP). STATISTICAL ANALYSIS USED: Patients were assessed before starting the treatment and at the end of 6 months on the basis of (a) Patient's self-assessment based on standardized seven-point scale compared with baseline (b) Physician's assessment based on standardized seven-point scale of hair growth compared with baseline. RESULTS: There was a significant improvement (P < 0.05) in both patients' assessment and investigator's assessment in Group B as compared to Group A at the end of 6 months. CONCLUSIONS: Microneedling with PRP is safe, effective, and a promising tool for the management of AGA.
format Online
Article
Text
id pubmed-5514790
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55147902017-07-31 A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia Shah, Kaksha B Shah, Aarti N Solanki, Rekha B Raval, Ranjan C Int J Trichology Original Article CONTEXT: There are very few studies evaluating efficacy of platelet-rich plasma (PRP) in hair restoration and its combination with microneedling. As far as ascertained, there is no study to evaluate efficacy of microneedling with PRP plus topical minoxidil (5%) versus topical minoxidil (5%) alone in androgenetic alopecia (AGA). AIMS: This study aims (1) to compare the efficacy of (a) topical minoxidil (5%) alone and (b) topical minoxidil (5%) + microneedling with PRP in men between 18 and 50 years with AGA Grade III to V vertex (Norwood–Hamilton scale) and (2) to perform objective and subjective evaluation based on clinical improvement and photographic evidence. SETTINGS AND DESIGN: The study was conducted in the outpatient department of dermatology, venereology, and leprology in tertiary care hospital. It was open, prospective study. SUBJECTS AND METHODS: Fifty patients with AGA were selected on the basis of inclusion and exclusion criteria. These patients were randomly divided into two groups of 25 patients each and were given following treatment: (i) Group A: topical minoxidil (5%) alone and (ii) Group B: topical minoxidil (5%) + microneedling with platelet-rich plasma (PRP). STATISTICAL ANALYSIS USED: Patients were assessed before starting the treatment and at the end of 6 months on the basis of (a) Patient's self-assessment based on standardized seven-point scale compared with baseline (b) Physician's assessment based on standardized seven-point scale of hair growth compared with baseline. RESULTS: There was a significant improvement (P < 0.05) in both patients' assessment and investigator's assessment in Group B as compared to Group A at the end of 6 months. CONCLUSIONS: Microneedling with PRP is safe, effective, and a promising tool for the management of AGA. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5514790/ /pubmed/28761259 http://dx.doi.org/10.4103/ijt.ijt_75_16 Text en Copyright: © 2017 International Journal of Trichology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Shah, Kaksha B
Shah, Aarti N
Solanki, Rekha B
Raval, Ranjan C
A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title_full A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title_fullStr A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title_full_unstemmed A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title_short A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
title_sort comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514790/
https://www.ncbi.nlm.nih.gov/pubmed/28761259
http://dx.doi.org/10.4103/ijt.ijt_75_16
work_keys_str_mv AT shahkakshab acomparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT shahaartin acomparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT solankirekhab acomparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT ravalranjanc acomparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT shahkakshab comparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT shahaartin comparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT solankirekhab comparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia
AT ravalranjanc comparativestudyofmicroneedlingwithplateletrichplasmaplustopicalminoxidil5andtopicalminoxidil5aloneinandrogeneticalopecia